ArticleJournal of medical systems2026
Development and Validation of an Automated Acute Kidney Injury E-Alert System Integrated with Clinical Decision Support for Hospitalized Patients.
Article in Journal of medical systems, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Automated electronic alerts integrated into inpatient electronic health records (EHRs) may improve recognition of moderate-to-severe acute kidney injury (AKI) and support timely medication review. An AKI e-alert system integrated with medication-focused clinical decision support (CDS) was implemented to identify adults with KDIGO stage 2-3 hospital-acquired AKI in near real time while minimizing alert burden. The alert logic used KDIGO serum creatinine (SCr) criteria, defined the operational real-time inpatient baseline as the lowest SCr value within the preceding seven days, and applied suppression rules for dialysis within seven days or imminent transfer/discharge. Alerts were generated through scheduled near-real-time processing four times daily and were accompanied by secure in-hospital medication guidance; the CDS did not automatically place orders. System performance was evaluated at a 2,768-bed tertiary medical center in Taiwan using EHR data from March 2018 to May 2023 and validated against a retrospective computerized reference algorithm designed to replicate the deployed logic. The system generated 3,946 stage 2-3 AKI alerts, achieving 90.94% sensitivity and 99.65% accuracy compared with the reference algorithm. Seasonal alert rates were highest in winter (4.48%) and lowest in summer (3.17%), supporting the temporal face validity of the detection approach. In a hospital-wide physician survey (n = 78), 63.0% agreed that the medication guidance accompanying alerts was clinically helpful. An EHR-integrated e-alert targeting advanced AKI can achieve high real-world performance, and linking alerts to targeted medication CDS may facilitate nephrotoxin stewardship and medication safety while limiting alert fatigue.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.